Literature DB >> 31391713

Modes of Calcium Regulation in Ischemic Neuron.

Vineeta Singh1, Vijaya Nath Mishra1, Rameshwar Nath Chaurasia1, Deepika Joshi1, Vibha Pandey1.   

Abstract

Calcium (Ca2+) dysregulation is a major catalytic event. Ca2+ dysregulation leads to neuronal cell death and brain damage result in cerebral ischemia. Neurons are unable in maintaining calcium homeostasis. Ca2+ homeostasis imbalance results in increased calcium influx and impaired calcium extrusion across the plasma membrane. Ca2+ dysregulation is mediated by different cellular and biochemical mechanism, which leads to neuronal loss resulting stroke/cerebral ischemia. A better understanding of the Ca2+ dysregulation might help in the development of new treatments in order to reduce ischemic brain injury. An optimal concentration of Ca2+ does not lead to neurotoxicity in the ischemic neuron. Intracellular Ca2+ act as a trigger for acute neurotoxicity and this cause induction of long-lasting processes leading to necrotic and/or apoptotic post-ischemic delayed neuronal death or of compensatory, neuroprotective mechanisms has increased considerably. Moreover, routes of ischemic Ca2+ influx to neurons, involvement of intracellular Ca2+ stores and Ca2+ buffers, spatial and temporal relations between ischemia-induced increases in intracellular Ca2+ concentration and neurotoxicity will further increase our understanding about underlying mechanism and they can act as a target for the development of drugs. Here, in our article we are trying to provide a brief overview of various Ca2+ influx pathways involve in ischemic neuron and how ischemic neuron attempts to counterbalance this calcium overload.

Entities:  

Keywords:  Calcium; Ischemia; Neurotoxicity

Year:  2019        PMID: 31391713      PMCID: PMC6660593          DOI: 10.1007/s12291-019-00838-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  45 in total

1.  Blocking the deadly effects of the NMDA receptor in stroke.

Authors:  Henry G S Martin; Yu Tian Wang
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

2.  Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial.

Authors:  J Horn; R J de Haan ; M Vermeulen; M Limburg
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

Review 3.  Neuronal voltage-gated calcium channels: structure, function, and dysfunction.

Authors:  Brett A Simms; Gerald W Zamponi
Journal:  Neuron       Date:  2014-04-02       Impact factor: 17.173

Review 4.  Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2.

Authors:  Akhlaq A Farooqui; Wei-Yi Ong; Lloyd A Horrocks
Journal:  Neurochem Res       Date:  2004-11       Impact factor: 3.996

5.  Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Authors:  K L Woods; S Fletcher; C Roffe; Y Haider
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

6.  Neuroprotection by the NR3A subunit of the NMDA receptor.

Authors:  Nobuki Nakanishi; Shichun Tu; Yeonsook Shin; Jiankun Cui; Toru Kurokawa; Dongxian Zhang; H-S Vincent Chen; Gary Tong; Stuart A Lipton
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

7.  Rapid glutamate receptor 2 trafficking during retinal degeneration.

Authors:  Yanhua Lin; Bryan W Jones; Aihua Liu; Félix R Vazquéz-Chona; J Scott Lauritzen; W Drew Ferrell; Robert E Marc
Journal:  Mol Neurodegener       Date:  2012-02-10       Impact factor: 14.195

8.  Ca permeable AMPA channels in diseases of the nervous system.

Authors:  John H Weiss
Journal:  Front Mol Neurosci       Date:  2011-11-14       Impact factor: 5.639

9.  Calcium and potassium channels in experimental subarachnoid hemorrhage and transient global ischemia.

Authors:  Marcel A Kamp; Maxine Dibué; Toni Schneider; Hans-Jakob Steiger; Daniel Hänggi
Journal:  Stroke Res Treat       Date:  2012-12-09

Review 10.  Metabolic crisis in severely head-injured patients: is ischemia just the tip of the iceberg?

Authors:  Emilie Carre; Michael Ogier; Henry Boret; Ambroise Montcriol; Lionel Bourdon; Risso Jean-Jacques
Journal:  Front Neurol       Date:  2013-10-11       Impact factor: 4.003

View more
  6 in total

1.  In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway.

Authors:  Shuang Wu; Tiantian Yang; Kai Cen; Yihuai Zou; Xiaowei Shi; Dongrui Zhou; Yonghong Gao; Limin Chai; Yizhou Zhao; Yikun Sun; Lingqun Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-31       Impact factor: 2.629

2.  Melatonin attenuates cerebral hypoperfusion-induced hippocampal damage and memory deficits in rats by suppressing TRPM7 channels.

Authors:  Hussain Al Dera; Mohammed Alassiri; Reem Al Kahtani; Samy M Eleawa; Mohammad K AlMulla; Abdulhakeem Alamri
Journal:  Saudi J Biol Sci       Date:  2022-01-18       Impact factor: 4.052

3.  GSK-126 Protects CA1 Neurons from H3K27me3-Mediated Apoptosis in Cerebral Ischemia.

Authors:  Zhongcheng Wang; Yaxin Su; Lei Zhang; Ting Lan; Li Li; Suhua Qi
Journal:  Mol Neurobiol       Date:  2022-01-29       Impact factor: 5.682

Review 4.  Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

Authors:  Khalil Mallah; Christine Couch; Davis M Borucki; Amer Toutonji; Mohammed Alshareef; Stephen Tomlinson
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

5.  ALG-bFGF Hydrogel Inhibiting Autophagy Contributes to Protection of Blood-Spinal Cord Barrier Integrity via PI3K/Akt/FOXO1/KLF4 Pathway After SCI.

Authors:  Renkan Zhang; Ling Xie; Fangfang Wu; Ji Xu; Leilei Lu; Lin Cao; Lei Li; Weiyang Meng; Hongyu Zhang; Chuxiao Shao; Xiaokun Li; Daqing Chen
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

6.  Inhibition of autophagy by CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR pathway contributes to ischemic postconditioning-induced neuroprotection against cerebral ischemia-reperfusion injury.

Authors:  Yuan Yao; Yingshi Ji; Jinghong Ren; Huanyu Liu; Rajesh Khanna; Li Sun
Journal:  Mol Brain       Date:  2021-08-06       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.